Interleukin-2This page contains recent news articles, when available, and an overview of Interleukin-2 but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.
WELT ONLINECeplene ® (histamine dihydrochloride) administered with low-dose interleukin-2 (IL-2) is the Company's treatment for the remission maintenance and ...
REG-Biocompatibles Intl.: Statement re Positive Data in Combination Therapy Trial - Nov 3, 2009
ReutersTreatment of patients with advanced renal cell carcinoma who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable ...
Major Advances in Clinical Cancer Research in 2009: A Report From ASCO - Nov 17, 2009
MedscapeA phase 3 trial showed that adding the vaccine to standard therapy with interleukin-2 more than doubled the response rate, and increased both ...
FDA Sanctions Gloucester Pharmaceuticals' Cutaneous T-Cell Lymphoma Therapy - Nov 6, 2009
Genetic Engineering News (press release)For example, Ontak is sanctioned specifically for use in CTCL that expresses the CD25 component of the interleukin-2 (IL-2) receptor. ...
Report Highlights Cancer Advances - Nov 9, 2009
MedPage TodayA vaccine that boosts the immune system's response to cancer doubled the response rate of melanoma when added to interleukin-2 (IL-2). ...
Incidence of Kidney Cancer Increasing - Oct 29, 2009
Space Coast Medicine and Healthy LivingDrugs in this category include interferon and interleukin-2, which are synthetic versions of chemicals made in the body. Biological therapy drugs are ...
Melanoma Research Foundation Leads Unprecedented Collaboration for Melanoma ... - Nov 3, 2009
ReutersInterleukin-2 (IL-2) was the last drug approved to treat advanced melanoma, but 85% of patients derive no benefit from this drug. The Consortium approach to ...
Phase I trial of an allogeneic gene-modified tumor cell vaccine (RCC-26/CD80 ... - Oct 29, 2009
UroToday...line RCC-26 displayed natural immunogenic potential that was enhanced through expression of CD80 costimulatory molecules and secretion of interleukin-2. ...
BioVex's $70M Series F to Fund Pivotal OncoVex Melanoma Trial - Nov 10, 2009
Therapeutics Daily (press release) (registration)Some metastatic melanoma patients currently are treated with the immunotherapy interleukin-2, and patients who respond usually go into durable remission. ...
Young mom gets help to head south for cancer fight - Nov 5, 2009
Winnipeg Free PressFor the record, Kaleena's "health insurance" -- government-funded health insurance of course -- covers not only the administering of interleukin 2, ...
More Tysabri Problems; Time for a Biogen-Idec Credibility Check - Oct 30, 2009
BNET...(TNF)-alpha antagonist Enbrel (Etanercept), the anti-CD52 antibody Campath (alemtuzumab), or the interleukin-2 receptor antibody Simulect (basiliximab). ...
Llega a la Argentina una nueva alternativa terapéutica para el cáncer de riñón. - Nov 9, 2009
Noticias Médicas (Comunicado de prensa)Además, se admitió a pacientes tratados previamente con bevacizumab, interferón alfa y interleukin-2. Los pacientes evaluados fueron distribuidos, ...
Wie Vitamin B12 bei atopischer Dermatitis wirken soll - Oct 28, 2009
DAZ.online - Das Internetportal der Deutschen Apotheker ZeitungSie sind verantwortlich für eine erhöhte Produktion von entzündungsfördernden Zytokinen wie Interleukin-1alpha, Interleukin-2, Interleukin-6 und Interferon ...
FDA Calendar Updates: Orexo, Novo Nordisk, King, Isis, Facet - 07 Aug 2009
Seeking AlphaDaclizumab is a humanized monoclonal antibody that binds to the alpha chain (CD25) of the interleukin-2 (IL-2) receptor on activated T cells,
S/he said - 07 Aug 2009
pride source.comGreg Louganis, in an article titled "Furry, Cuddly, Lifesaving," recalling the grueling interleukin-2 treatments he was taking to boost his CD4-cell count,
Novel Therapeutics for Melanoma - Jul 28, 2009
MedscapeHigh-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993. J. Clin. Oncol.
Afinitor® approved in EU as first treatment proven to benefit ... - Aug 5, 2009
PR-Inside.com (Pressemitteilung)Prior therapy with bevacizumab, interferon alfa and interleukin-2 was allowed. Patients were randomized to receive Afinitor (10 mg) daily or placebo,
Vical and Teva Establish Sales and Marketing Agreement for ... - Aug 3, 2009
GlobeNewsWire (press release)The toxicity associated with FDA-approved treatments such as dacarbazine or interleukin-2 is often significant, resulting in serious or life-threatening
Long-acting beta-2-agonists have no major anti-inflammatory effects - Aug 1, 2009
news Stories...neutrophil count, it had no effect on serum interleukin-2 receptor levels or on any inflammatory marker in any of the airway compartments studied.
Prediction of response to combined immunotherapy with interferon ... - Jul 21, 2009
UroToday...immunotherapy with interferon-alpha (IFN-alpha) and low-dose interleukin-2 (IL-2) and to identify factors predicting susceptibility to this therapy.
Phase I/II open-label study of the biologic effects of the ... - Jul 29, 2009
7thSpace Interactive (press release)To explore the biological activity of EMD 273063 (hu14.18-IL2), a humanized anti-GD2 monoclonal antibody fused to interleukin-2 (IL2), in patients with
Professor Receives Cancer Institute Award - Jul 13, 2009
USC NewsThe reagent he developed along with co-worker Peisheng Hu is an analog of Interleukin-2 (IL-2), an important therapeutic for cancer patients.
Flu Shots Not as Effective in Lupus - Jul 31, 2009
MedPage Today...tumor necrosis factor and interleukin-2 -- was less than half that of controls, both at baseline and after vaccination (P<0.001 for both comparisons).
Bristol's Cancer Bet - Jul 23, 2009
ForbesAnother immune-boosting therapy against cancer, the natural immune system protein interleukin-2, has been limited by severe side effects.
USC Researcher Wins $3.5M NCI RAID Award to Fund Spinout Pivotal ... - Jul 14, 2009
GenomeWeb Daily NewsThe most recent RAID award will support preclinical development of an interleukin-2 cytokine immunotherapy analog discovered by Epstein, a professor of
Nexavar® In Combination With Chemotherapy Shown To Extend ... - Jul 25, 2009
Medical News Today (press release)...advanced renal cell carcinoma (RCC) who have failed prior interferon-alpha or interleukin-2 based therapy or are considered unsuitable for such therapy.
EpiCept begins post-approval clinical study with Ceplene - Jul 15, 2009
pharmabiz.comCeplene is to be administered in conjunction with low-dose interleukin-2 (IL-2). This study will enrol up to 150 patients at approximately 25 centers across
Clinic fundraisers to aid Hunt family - Jul 15, 2009
Windsor Star...the only place where he was able to get Interleukin-2, a protein that stimulates the immune system and the production of infection-fighting cells.
Afinitor - nytt hopp för patienter med spridd njurcancer - Aug 5, 2009
Newsdesk (pressmeddelande)Även patienter som hade behandlats med bevacizumab, interferon alfa och interleukin-2 deltog i studien. Resultaten var så goda att studien avbröts i förtid
Brustkrebs - Überlebenszeit verlängert durch Kombinationstherapie ... - Jul 27, 2009
Medizin-Aspekte...bei denen eine Behandlung mit Interferon-alpha oder Interleukin-2 nicht angeschlagen hat oder die für eine solche Therapie nicht in Frage kommen.
Background information on Interleukin-2 [When available]
Biological therapy is a type of treatment that works with your immune system. It can help fight cancer or help control side effects (how your body reacts to the drugs you are taking) from other cancer treatments like chemotherapy.
What is the difference between biological therapy and chemotherapy?
Biological therapy and chemotherapy are both treatments that fight cancer. While they may seem alike, they work in different ways. Biological therapy helps your immune system fight cancer. Chemotherapy attacks the cancer cells directly.
How does biological therapy fight cancer?
Doctors are not sure how biological therapy helps your immune system fight cancer. But they think it may:
Search the web for more resources on Interleukin-2
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines
The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy